Loading MRNA charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading MRNA comparable companies…
| MRNAModerna, Inc.(opens in a new tab) | $88.20B | $2.23B | −27.6% | 23.4% | −149.0% | 39.59× | — |
|---|---|---|---|---|---|---|---|
| EXELExelixis, Inc.(opens in a new tab) | $17.75B | $2.50B | +9.1% | 96.3% | 40.2% | 7.11× | 20.8× |
| HALOHalozyme Therapeutics, Inc.(opens in a new tab) | $15.87B | $1.66B | +41.2% | 82.4% | 35.9% | 9.54× | 38.2× |
| BNTXBioNTech SE(opens in a new tab) | $21.31B | $3.24B | +9.0% | 77.6% | −49.0% | 6.57× | — |
| NBIXNeurocrine Biosciences Inc.(opens in a new tab) | $15.23B | $3.37B | +34.4% | 98.0% | 23.6% | 4.51× | 21.4× |
| Medianpeers, excl. MRNA | $16.81B | $2.87B | +21.8% | 89.3% | 29.7% | 6.84× | 21.4× |